E Fund Management Co.,LTD. logo

E Fund Management Co.,LTD.

Asia, Hong Kong Island, Hong Kong, Central

Description

E Fund Management Co., Ltd. ("E Fund") is a fund management company.

Investor Profile

E Fund Management Co.,LTD. has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 5 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Private Equity, Series D, Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Manufacturing, Medical, Biotechnology.

Stage Focus

  • Private Equity (25%)
  • Series D (25%)
  • Series C (25%)
  • Post Ipo Equity (25%)

Country Focus

  • China (100%)

Industry Focus

  • Manufacturing
  • Medical
  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical Device
  • Robotics
  • Biopharma
  • Consumer Electronics
  • Electronics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does E Fund Management Co.,LTD. frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
GL Ventures LLC
Asia, Beijing, China, Beijing
Co-Investments: 1
Advantech Capital
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
Hillhouse Investment
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Grand Flight Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
AC
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
BC
Europe, Hovedstaden, Denmark, Bagsværd
Co-Investments: 1
CPE
Asia, Beijing, China, Beijing
Co-Investments: 1
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
Dyee Capital
Asia, Fujian, China, Xiamen
Co-Investments: 1

What are some of recent deals done by E Fund Management Co.,LTD.?

Loctek Ergonomic Technology

Ningbo, Zhejiang, China

Loctek Ergonomic Technology manufactures ergonomic products.

Consumer ElectronicsElectronicsManufacturing
Post Ipo EquitySep 30, 2021
Amount Raised: $108,570,542
Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738
InventisBio

Shanghai, Shanghai, China

InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.

BiopharmaBiotechnologyPharmaceutical
Series DSep 27, 2020
Amount Raised: $147,000,000
MicroPort Medbot

Shanghai, Shanghai, China

MicroPort Medbot develops and provides intelligent surgical solutions and clinical needs.

Health CareManufacturingMedicalMedical DeviceRobotics
Private EquitySep 7, 2020
Amount Raised: $512,407,584